• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较淀粉样变多发性骨髓瘤或患者的 IGLV2-14 轻链序列。

Comparison of IGLV2-14 light chain sequences of patients with AL amyloidosis or multiple myeloma.

机构信息

Medical Department V, Amyloidosis Center, Heidelberg University Hospital, Germany.

Medical Department V, Section of Multiple Myeloma, Heidelberg University Hospital, Germany.

出版信息

FEBS J. 2023 Sep;290(17):4256-4267. doi: 10.1111/febs.16805. Epub 2023 Jun 8.

DOI:10.1111/febs.16805
PMID:37097223
Abstract

Light chain amyloidosis (AL) is one of the most common forms of systemic amyloidosis and is caused by the deposition of insoluble fibrils derived from misfolded and aggregated immunoglobulin light chains (LC). To uncover the causes leading to this aggregation, we compared AL LC sequences with those of patients with the related disease multiple myeloma (MM), which do not aggregate in insoluble fibrils in vivo. IGLV2-14 is one of the most common AL-associated IGLV subfamilies. Here, we analysed IGLV2-14 LC sequences of 13 AL and eight MM patients in detail. We found that AL-associated LCs presented a lower median mutation count (7.0 vs. 11.5 in MM; P = 0.045), as well as an overall composition of less charged amino acids than MM LCs. However, we did not find a mutation that was present in ≥ 50% of the AL and not in the MM sequences. Furthermore, we did not find a significant difference in the isoelectric point (pI) in general, suggesting similar stability of the LCs in AL and MM. However, the subgroup of patients without a detectable heavy chain stood out. Surprisingly, they are characterized by an increase in mutation count (median 7.0 vs. 5.5) and pI (median 7.82 vs. 6.44, P = 0.043). In conclusion, our data suggest that the amount of mutations and the introduction of charges play a crucial role in AL fibril formation, as well as the absence or presence of a potential heavy chain binding partner.

摘要

轻链淀粉样变性(AL)是最常见的系统性淀粉样变性形式之一,是由错误折叠和聚集的免疫球蛋白轻链(LC)衍生的不溶性纤维的沉积引起的。为了揭示导致这种聚集的原因,我们将 AL LC 序列与相关疾病多发性骨髓瘤(MM)的患者序列进行了比较,后者在体内不会以不溶性纤维的形式聚集。IGLV2-14 是最常见的与 AL 相关的 IGLV 亚家族之一。在这里,我们详细分析了 13 名 AL 和 8 名 MM 患者的 IGLV2-14 LC 序列。我们发现,AL 相关的 LCs 突变中位数较低(7.0 对 MM 的 11.5;P=0.045),并且整体组成中带电荷的氨基酸较少。然而,我们没有发现一个突变在 AL 中存在于≥50%的患者而在 MM 序列中不存在。此外,我们一般没有发现等电点(pI)有显著差异,这表明 AL 和 MM 中的 LC 稳定性相似。然而,没有检测到重链的患者亚组引人注目。令人惊讶的是,它们的突变计数(中位数 7.0 对 5.5)和 pI(中位数 7.82 对 6.44,P=0.043)增加。总之,我们的数据表明,突变数量和电荷的引入在 AL 纤维形成中起着至关重要的作用,以及潜在的重链结合伴侣的缺失或存在。

相似文献

1
Comparison of IGLV2-14 light chain sequences of patients with AL amyloidosis or multiple myeloma.比较淀粉样变多发性骨髓瘤或患者的 IGLV2-14 轻链序列。
FEBS J. 2023 Sep;290(17):4256-4267. doi: 10.1111/febs.16805. Epub 2023 Jun 8.
2
Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis.免疫球蛋白轻链特定结构区域的突变与AL淀粉样变性患者的游离轻链水平相关。
PLoS One. 2009;4(4):e5169. doi: 10.1371/journal.pone.0005169. Epub 2009 Apr 13.
3
Amyloidogenic light chains impair plasma cell survival.淀粉样轻链可损害浆细胞存活。
Haematologica. 2023 Dec 1;108(12):3359-3371. doi: 10.3324/haematol.2022.282484.
4
Differential recruitment efficacy of patient-derived amyloidogenic and myeloma light chain proteins by synthetic fibrils-A metric for predicting amyloid propensity.合成原纤维对患者来源的淀粉样生成蛋白和骨髓瘤轻链蛋白的差异募集效力——一种预测淀粉样蛋白倾向的指标
PLoS One. 2017 Mar 28;12(3):e0174152. doi: 10.1371/journal.pone.0174152. eCollection 2017.
5
An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis.免疫球蛋白 κ 轻链中的 N-糖基化热点与 AL 淀粉样变性有关。
Leukemia. 2022 Aug;36(8):2076-2085. doi: 10.1038/s41375-022-01599-w. Epub 2022 May 24.
6
Assessment of renal response with urinary exosomes in patients with AL amyloidosis: A proof of concept.评估 AL 淀粉样变性患者尿液外泌体的肾反应:概念验证。
Am J Hematol. 2017 Jun;92(6):536-541. doi: 10.1002/ajh.24717. Epub 2017 May 4.
7
Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myeloma.κ 轻链淀粉样变多发性骨髓瘤患者κ 轻链序列多样性。
Amyloid. 2024 Jun;31(2):86-94. doi: 10.1080/13506129.2023.2295221. Epub 2024 Jan 11.
8
Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.患者抗体轻链中的致命淀粉样形成是由单个点突变引起的。
Elife. 2020 Mar 10;9:e52300. doi: 10.7554/eLife.52300.
9
Aggregation of Full-length Immunoglobulin Light Chains from Systemic Light Chain Amyloidosis (AL) Patients Is Remodeled by Epigallocatechin-3-gallate.表没食子儿茶素-3-没食子酸酯重塑系统性轻链淀粉样变性(AL)患者全长免疫球蛋白轻链的聚集。
J Biol Chem. 2017 Feb 10;292(6):2328-2344. doi: 10.1074/jbc.M116.750323. Epub 2016 Dec 28.
10
A constant domain mutation in a patient-derived antibody light chain reveals principles of AL amyloidosis.患者源性抗体轻链中的恒定域突变揭示了 AL 淀粉样变性的原理。
Commun Biol. 2023 Feb 23;6(1):209. doi: 10.1038/s42003-023-04574-y.

引用本文的文献

1
Clone-specific residue changes at multiple positions are associated with amyloid formation by antibody light chains.多个位置上的克隆特异性残基变化与抗体轻链的淀粉样蛋白形成有关。
Front Immunol. 2025 Aug 1;16:1622207. doi: 10.3389/fimmu.2025.1622207. eCollection 2025.
2
An updated AL-base reveals ranked enrichment of immunoglobulin light chain variable genes in AL amyloidosis.更新后的AL数据库揭示了AL淀粉样变性中免疫球蛋白轻链可变基因的排名富集情况。
Amyloid. 2025 Jun;32(2):129-138. doi: 10.1080/13506129.2024.2434899. Epub 2024 Dec 6.
3
An updated AL-Base reveals ranked enrichment of immunoglobulin light chain variable genes in AL amyloidosis.
一份更新的AL数据库显示,在AL淀粉样变性中免疫球蛋白轻链可变基因存在排名富集现象。
bioRxiv. 2024 Sep 15:2024.09.11.612490. doi: 10.1101/2024.09.11.612490.